Abstract
This study by Franklin, et. al., reported that the use of the Biodesign Hernia Graft results in minimal recurrence with 5+ year follow-up. Recurrence was reported at just 5.3%.
Cook Biotech is now part of RTI Surgical.
See the press release about this acquisition for more information.
This study by Franklin, et. al., reported that the use of the Biodesign Hernia Graft results in minimal recurrence with 5+ year follow-up. Recurrence was reported at just 5.3%.